Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sio Gene Therapies Inc (SIOX)

Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sio Gene Therapies Inc 1501 Broadway 12th Floor NEW YORK NY 10036 USA

www.siogtx.com P: 646-677-6770

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Sio Gene Therapies Inc. is a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. Its product candidate includes AXO-AAV-GM1 and AXO-AAV-GM. Sio Gene Therapies Inc., formerly known as Axovant Gene Therapies Ltd., is based in New York.

Key Statistics

Overview:

Market Capitalization, $K 34,865
Enterprise Value, $K -30,045
Shares Outstanding, K 72,940
Float, K 70,460
% Float 96.60%
Short Volume Ratio 0.80
% of Insider Shareholders 3.40%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -71,890 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -4,020 K
EBIT, $ -29,370 K
EBITDA, $ -28,700 K

Growth:

1-Year Return 4.99%
3-Year Return -85.56%
5-Year Return -94.98%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.05 on 02/14/23
Next Earnings Date 04/02/24
Earnings Per Share ttm -0.20
EPS Growth vs. Prev Year -55.29%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 05/08/19

SIOX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.62
Interest Coverage -2,386.67
60-Month Beta 1.10
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar